Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-30

Clinical Trial Update: Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial of psilocybin-assisted cognitive processing therapy for chronic PTSD is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Post Traumatic Stress Disorder, PTSD | Phase 2 | Status: NOT_YET_RECRUITING